INHIBITION OF MALIGNANT-CELL GROWTH BY KETONE-BODIES
INHIBITION OF MALIGNANT-CELL GROWTH BY KETONE-BODIES
复制标题
DOI:
10.1038/icb.1979.54
复制
发表时间:
1979-01-01
期刊:
影响因子:
--
通讯作者:
CONYERS, RAJ
中科院分区:
文献类型:
--
作者:
MAGEE, BA;POTEZNY, N;CONYERS, RAJ
The effect of ketone bodies on the growth, in culture, of transformed lymphoblasts ([human Burkitt''s lymphoma] Raji cells) was investigated. Cell growth was inhibited and this effect was reversible, non-toxic and proportional to the concentration of D-.beta.-hydroxybutyrate up to 20 mM. The total glucose utilization and the total lactate production were reduced in proportion to the inhibition of cell proliferation. D-.beta.-hydroxybutyrate was not metabolized by the cells. Other glycolytic inhibitors and chemical analogues of D-.beta.-hydroxybutyrate did not inhibit or proved to be too toxic for cell growth. D-.beta.-hydroxybutyrate inhibited the growth of rabbit kidney RK13, [human cervical carcinoma] HeLa, mouse melanoma B16, fibroblast and trypsin-dispersed human thyroid and beef testis cells. In vivo dietary-induced ketosis reduced the number of B16 melanoma deposits in the lungs of C57BL/6 mice by 2/3. The significance of these results in the clinical management of cancer cachexia is discussed.